The audit at Indrad plant of the company was carried out by the United
States Food and Drug Administration (USFDA) in April.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/usfda-makes-certain-observations-for-torrent-pharmas-indrad-plant/articleshow/69053644.cms
No comments:
Post a Comment